Link to this page
Medical Dictionary for Regulatory Activities Terminology (MedDRA)
| Id | http://purl.bioontology.org/ontology/MEDDRA/20000136
http://purl.bioontology.org/ontology/MEDDRA/20000136
|
|---|---|
| Preferred Name | Extravasation events (injections, infusions and implants) (SMQ) |
| Definitions |
Extravasation of drug product administered by venous access is a local complication and can be associated with pain and swelling. Some products may be associated with more serious sequelae including tissues necrosis. May be caused by: damage to the posterior wall of the vein or occlusion of the vein proximal to the injection site; occlusion of vein proximal to injection site. Extravasation is broadly defined as discharge or escape of blood or other fluid normally found in a vessel or tube, into the surrounding tissues. For purposes of this SMQ, "extravasation" relates to complication of drug delivery (injection, infusion, etc.) or to a device (includes potential sequelae of extravasation). Pain, erythema, and swelling are typically observed.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | Extravasation of drug product administered by venous access is a local complication and can be associated with pain and swelling. Some products may be associated with more serious sequelae including tissues necrosis. May be caused by: damage to the posterior wall of the vein or occlusion of the vein proximal to the injection site; occlusion of vein proximal to injection site. Extravasation is broadly defined as discharge or escape of blood or other fluid normally found in a vessel or tube, into the surrounding tissues. For purposes of this SMQ, "extravasation" relates to complication of drug delivery (injection, infusion, etc.) or to a device (includes potential sequelae of extravasation). Pain, erythema, and swelling are typically observed. |
|---|---|
| prefLabel | Extravasation events (injections, infusions and implants) (SMQ)
|
| SMQ STATUS | A
|
| type | |
| tui | T185
|
| notation | 20000136
|
| SMQ LEVEL | 1
|
| Semantic type UMLS property | |
| SMQ ALGO | N
|
| Scope Statement | NOTE: Administration site pain and erythema are symptoms of extravasation (and are currently included in this SMQ) but can occur without it. These terms could retrieve more cases of interest than is practical in certain databases, depending on coding practices. This should be borne in mind when applying this SMQ. In general, "application site" terms are considered not appropriate for the scope of this SMQ, even though they did retrieve a few cases of interest during pre-production testing. MedDRA users should consider - based on their own data - if "application site" terms may have been used when coding cases related to extravasation and include relevant terms as needed. Users should consider including cases coded to LLT Catheter related complication. This term is not currently linked to an included PT in this SMQ, but may retrieve cases of interest.
|
| cui | C1964005
|
| SMQ SOURCE | Brown, S. Complications with the Use of Venous Access Devices. U.S. Pharmacist. http://www.uspharmacist.com/oldformat.asp?url=newlook/files/Feat/ACF2FF9.cfm&pub_id=8&article_id=131; Stedman's Medical Dictionary, 27th Edition, 2000; Wickham, R. Long-Term Central Venous Catheters: Issues for Care. Semin Oncol Nurs 1992;8,2(May):133-147
|
| Has member |
See more
See less
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |